Making Stem Cells


with Everyone

Embryoid bodies, fluorescent light micrograph

Editing Stem Cells to Cure Disease

3D rendering of recombinant Adeno-Associated Virus


Universal Cells creates Universal Donor Stem Cells by editing the genes required for immune recognition. By using our recombinant Adeno-Associated Virus (rAAV) technology, we design and manufacture stem cell-based products that can be used as off-the-shelf cell therapies.

Our Technology

One Universal Stem Cell Bank


Universal Donor Cells are pluripotent and can differentiate into various cell types that can be used to treat a vast number of diseases. Learn more about the Universal Cells’ pipeline and partnerships.


Latest News

Astellas Acquires Universal Cells, Inc.

February 14th, 2018|1 Comment

Acquisition enables Astellas to fully utilize proprietary technology to produce pluripotent stem cells that have the potential to lower immunological rejection in numerous therapeutic areas Tokyo, February 13, 2018 - Astellas Pharma Inc. (TSE: 4503, [...]

Astellas and Universal Cells, Inc. Announce a Collaboration Utilizing Universal Donor Cell Technology

October 20th, 2017|0 Comments

Tokyo, October 19, 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Universal Cells, Inc. (CEO: Claudia Mitchell, “Universal Cells”) today announced that Astellas Institute for Regenerative Medicine (“AIRM”) and [...]

Cell and Gene Therapy Catapult Licenses iPSC Line to Universal Cells to assist in the Development of Universal Donor Cell Line

October 5th, 2017|0 Comments

Universal Cells to utilise CGT Catapult’s induced Pluripotent Stem Cells to create universally accepted cells for research and commercial use London, UK, 5 October 2017 – The Cell and Gene Therapy Catapult (CGT Catapult) today [...]